Urinary MRD Status Potentially Predictive of Recurrence in B

Assessment of urinary MRD status identified and enabled quantification of molecular responses with nadofaragene firadenovec in BCG-unresponsive NMIBC.

Related Keywords

United States , Vikramm Narayan , , Intravesical Administration , Ferring Pharmaceuticals , Urology At Emory University School Of Medicine , Emory University School , Clin Oncol , Medicine Clinical Trials , Patients With , Relapsed Bladder , Bladder Cancer , Nmibc , Bacillus Calmette Guérin Bcg Unresponsive , High Grade , Non Muscle Invasive Bladder Cancer , Hase 2 Trial Nct01687244 , Mrd Status , Minimal Residual Disease ,